Detalhe da pesquisa
1.
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residues.
Bioorg Med Chem Lett
; 19(3): 981-5, 2009 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19095443
2.
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroups.
Bioorg Med Chem Lett
; 19(3): 976-80, 2009 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19095442